David Bartlett

David Bartlett is a leading surgical oncologist who has contributed substantially to the evidence base for peritoneal surface oncology. His research has investigated outcomes after cytoreductive surgery and HIPEC for appendiceal neoplasms, colorectal cancer, and other peritoneal malignancies. He has conducted landmark clinical trials on regional chemotherapy delivery and led multi-institutional studies on patient selection criteria for peritoneal carcinomatosis surgery. His work has helped define which patients benefit most from this intensive treatment approach.